SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Boyages J.)
 

Search: WFRF:(Boyages J.) > (2013) > Breast cancer survi...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Walters, S. (author)

Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000-2007 : a population-based study

  • Article/chapterEnglish2013

Publisher, publication year, extent ...

  • 2013-02-28
  • Springer Science and Business Media LLC,2013
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-199729
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-199729URI
  • https://doi.org/10.1038/bjc.2013.6DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:126504355URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: We investigate whether differences in breast cancer survival in six high-income countries can be explained by differences in stage at diagnosis using routine data from population-based cancer registries. Methods: We analysed the data on 257 362 women diagnosed with breast cancer during 2000-7 and registered in 13 population-based cancer registries in Australia, Canada, Denmark, Norway, Sweden and the UK. Flexible parametric hazard models were used to estimate net survival and the excess hazard of dying from breast cancer up to 3 years after diagnosis. Results: Age-standardised 3-year net survival was 87-89% in the UK and Denmark, and 91-94% in the other four countries. Stage at diagnosis was relatively advanced in Denmark: only 30% of women had Tumour, Nodes, Metastasis (TNM) stage I disease, compared with 42-45% elsewhere. Women in the UK had low survival for TNM stage III-IV disease compared with other countries. Conclusion: International differences in breast cancer survival are partly explained by differences in stage at diagnosis, and partly by differences in stage-specific survival. Low overall survival arises if the stage distribution is adverse (e. g. Denmark) but stage-specific survival is normal; or if the stage distribution is typical but stage-specific survival is low (e. g. UK). International differences in staging diagnostics and stage-specific cancer therapies should be investigated.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Maringe, C. (author)
  • Butler, J. (author)
  • Rachet, B. (author)
  • Barrett-Lee, P. (author)
  • Bergh, J.Karolinska Institutet (author)
  • Boyages, J. (author)
  • Christiansen, P. (author)
  • Lee, M. (author)
  • Wärnberg, FredrikUppsala universitet,Endokrinkirurgi(Swepub:uu)fredwarn (author)
  • Allemani, C. (author)
  • Engholm, G. (author)
  • Fornander, T.Karolinska Institutet (author)
  • Gjerstorff, M. L. (author)
  • Johannesen, T. B. (author)
  • Lawrence, G. (author)
  • McGahan, C. E. (author)
  • Middleton, R. (author)
  • Steward, J. (author)
  • Tracey, E. (author)
  • Turner, D. (author)
  • Richards, M. A. (author)
  • Coleman, M. P. (author)
  • Karolinska InstitutetEndokrinkirurgi (creator_code:org_t)

Related titles

  • In:British Journal of Cancer: Springer Science and Business Media LLC108:5, s. 1195-12080007-09201532-1827

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view